| Product Code: ETC7623333 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland saw a significant increase in antivirals import shipments, with top exporting countries being Germany, UK, USA, Canada, and other areas. The market concentration, as measured by the HHI, shifted from moderate to high concentration within a year. This trend indicates a growing reliance on a smaller number of suppliers. With a remarkable CAGR of 23.25% from 2020 to 2024 and a rapid growth rate of 68.68% in 2024 alone, the antivirals market in Ireland is displaying robust expansion and potential for further development.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Antivirals Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Antivirals Market - Industry Life Cycle |
3.4 Ireland Antivirals Market - Porter's Five Forces |
3.5 Ireland Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 Ireland Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Ireland |
4.2.2 Growing awareness about the importance of antiviral medications |
4.2.3 Technological advancements leading to the development of more effective antivirals |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antiviral drugs |
4.3.2 High cost associated with research and development of antiviral medications |
4.3.3 Competition from generic antiviral drugs impacting market pricing |
5 Ireland Antivirals Market Trends |
6 Ireland Antivirals Market, By Types |
6.1 Ireland Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 Ireland Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 Ireland Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 Ireland Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 Ireland Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 Ireland Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Ireland Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 Ireland Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 Ireland Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 Ireland Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Antivirals Market Import-Export Trade Statistics |
7.1 Ireland Antivirals Market Export to Major Countries |
7.2 Ireland Antivirals Market Imports from Major Countries |
8 Ireland Antivirals Market Key Performance Indicators |
8.1 Number of new antiviral drug approvals in Ireland |
8.2 Adoption rate of antiviral medications among healthcare providers |
8.3 Research and development investment in the antivirals market |
8.4 Patient adherence and compliance rates for antiviral treatments |
8.5 Number of reported cases of viral infections in Ireland |
9 Ireland Antivirals Market - Opportunity Assessment |
9.1 Ireland Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 Ireland Antivirals Market - Competitive Landscape |
10.1 Ireland Antivirals Market Revenue Share, By Companies, 2024 |
10.2 Ireland Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |